Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2016 (2016), Article ID 6420408, 6 pages
http://dx.doi.org/10.1155/2016/6420408
Research Article

Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients

1Section of Hepatology, Department of Internal Medicine, University of Manitoba, 804D-715 McDermot Avenue, Winnipeg, MB, Canada R3E 3P4
2Division of Gastroenterology, University of Western Ontario, Room ALL-107, 339 Windermere Road, London, ON, Canada N6A 5A5

Received 29 October 2015; Accepted 25 February 2016

Academic Editor: Eric M. Yoshida

Copyright © 2016 Julia Uhanova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Vernon, A. Baranova, and Z. M. Younossi, “Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults,” Alimentary Pharmacology and Therapeutics, vol. 34, no. 3, pp. 274–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Lazo, R. Hernaez, S. Bonekamp et al., “Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study,” BMJ, vol. 343, no. 7836, Article ID d6891, p. 1245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Lazo, R. Hernaez, M. S. Eberhardt et al., “Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994,” American Journal of Epidemiology, vol. 178, no. 1, pp. 38–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Bellentani, F. Scaglioni, M. Marino, and G. Bedogni, “Epidemiology of non-alcoholic fatty liver disease,” Digestive Diseases, vol. 28, no. 1, pp. 155–161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Imbeault, F. Haman, J. M. Blais et al., “Obesity and type 2 diabetes prevalence in adults from two remote first nations communities in northwestern Ontario,” Journal of Obesity, vol. 2011, Article ID 267509, 5 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. J. A. Foulds, S. S. D. Bredin, and D. E. R. Warburton, “The prevalence of overweight and obesity in British Columbian Aboriginal adults,” Obesity Reviews, vol. 12, no. 501, pp. e4–e11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. G. Bruce, N. D. Riediger, J. M. Zacharias, and T. K. Young, “Obesity and obesity-related comorbidities in a Canadian First Nation population,” Preventing Chronic Disease, vol. 8, no. 1, article A03, 2011. View at Google Scholar
  8. M.-L. Chateau-Degat, D. Pereg, G. M. Egeland et al., “Diabetes and related metabolic conditions in an aboriginal cree community of Quebec, Canada,” Canadian Journal of Diabetes, vol. 33, no. 3, pp. 156–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. N. D. Riediger, L. M. Lix, V. Lukianchuk, and S. Bruce, “Trends in diabetes and cardiometabolic conditions in a Canadian First Nation community, 2002–2003 to 2011-2012,” Preventing Chronic Disease, vol. 11, article E198, 2014. View at Google Scholar
  10. C. Green, J. F. Blanchard, T. K. Young, and J. Griffith, “The epidemiology of diabetes in the Manitoba-Registered First Nation Population: current patterns and comparative trends,” Diabetes Care, vol. 26, no. 7, pp. 1993–1998, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Marchesini and R. Marzocchi, “Metabolic syndrome and NASH,” Clinics in Liver Disease, vol. 11, no. 1, pp. 105–117, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. B. Moore, “Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome,” Proceedings of the Nutrition Society, vol. 69, no. 2, pp. 211–220, 2010. View at Google Scholar
  13. G. Bedogni, L. Miglioli, F. Masutti, C. Tiribelli, G. Marchesini, and S. Bellentani, “Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver study,” Hepatology, vol. 42, no. 1, pp. 44–52, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Marchesini, M. Brizi, G. Blanchi et al., “Nonalcoholic fatty liver disease: a feature of the metabolic syndrome,” Diabetes, vol. 50, no. 8, pp. 1844–1850, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. E. K. Speliotes, J. M. Massaro, U. Hoffmann et al., “Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham heart study,” Hepatology, vol. 51, no. 6, pp. 1979–1987, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. D. Williams, J. Stengel, M. I. Asike et al., “Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study,” Gastroenterology, vol. 140, no. 1, pp. 124–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. I. R. Wanless and J. S. Lentz, “Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors,” Hepatology, vol. 12, no. 5, pp. 1106–1110, 1990. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Caldwell and C. Argo, “The natural history of non-alcoholic fatty liver disease,” Digestive Diseases, vol. 28, no. 1, pp. 162–168, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. L. S. Szczepaniak, P. Nurenberg, D. Leonard et al., “Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population,” American Journal of Physiology—Endocrinology and Metabolism, vol. 288, no. 2, pp. E462–E468, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. F. L. Cobbold, Q. M. Anstee, and S. D. Taylor-Robinson, “The importance of fatty liver disease in clinical practice,” Proceedings of the Nutrition Society, vol. 69, no. 4, pp. 518–527, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Goessling, J. M. Massaro, R. S. Vasan, R. B. D'Agostino Sr., R. C. Ellison, and C. S. Fox, “Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease,” Gastroenterology, vol. 135, no. 6, pp. 1935–1944.e1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Maximos, F. Bril, P. Portillo Sanchez et al., “The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease,” Hepatology, vol. 61, no. 1, pp. 153–160, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Y. Jung, S. Y. Cho, H. J. Kim, S. B. Kim, and I. H. Song, “Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology,” Journal of Clinical Gastroenterology, vol. 48, no. 10, pp. 883–888, 2014. View at Google Scholar · View at Scopus
  24. Z. M. Younossi, A. B. Koenig, D. Abdelatif, Y. Fazel, L. Henry, and M. Wymer, “Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes,” Hepatology, 2015. View at Publisher · View at Google Scholar
  25. G. C. Farrell and C. Z. Larter, “Nonalcoholic fatty liver disease: from steatosis to cirrhosis,” Hepatology, vol. 43, no. 2, pp. S99–S112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. G. A. Michelotti, M. V. Machado, and A. M. Diehl, “NAFLD, NASH and liver cancer,” Nature Reviews Gastroenterology and Hepatology, vol. 10, no. 11, pp. 656–665, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. N. N. Than and P. N. Newsome, “A concise review of non-alcoholic fatty liver disease,” Atherosclerosis, vol. 239, no. 1, pp. 192–202, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Armstrong, D. D. Houlihan, L. Bentham et al., “Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort,” Journal of Hepatology, vol. 56, no. 1, pp. 234–240, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Watanabe, E. Hashimoto, K. Ikejima et al., “Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis,” Journal of Gastroenterology, vol. 50, no. 4, pp. 364–377, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. B. N. Bohinc and A. M. Diehl, “Mechanisms of disease progression in NASH: new paradigms,” Clinics in Liver Disease, vol. 16, no. 3, pp. 549–565, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Di Rosa and L. Malaguarnera, “Genetic variants in candidate genes influencing NAFLD progression,” Journal of Molecular Medicine, vol. 90, no. 2, pp. 105–118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Dongiovanni, S. Romeo, and L. Valenti, “Genetic factors in the pathogenesis of nonalcoholic fatty liver and steatohepatitis,” BioMed Research International, vol. 2015, Article ID 460190, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. C. P. Oliveira and J. T. Stefano, “Genetic polymorphisms and oxidative stress in non-alcoholic steatohepatitis (NASH): a mini review,” Clinics and Research in Hepatology and Gastroenterology, vol. 39, supplement 1, pp. S35–S40, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Vonghia, P. Michielsen, and S. Francque, “Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis,” International Journal of Molecular Sciences, vol. 14, no. 10, pp. 19867–19890, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. E. W. Holt, “Describing the role of ethnicity in the progression of NAFLD: easier said than done?” Hepatology, vol. 56, no. 5, p. 2005, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-J. Pan and M. B. Fallon, “Gender and racial differences in nonalcoholic fatty liver disease,” World Journal of Hepatology, vol. 6, no. 5, pp. 274–283, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Vong and B. P. Bell, “Chronic liver disease mortality in the United States, 1990–1998,” Hepatology, vol. 39, no. 2, pp. 476–483, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. J. D. Rempel, K. Hawkins, E. Lande, and P. Nickerson, “The potential influence of KIR cluster profiles on disease patterns of Canadian Aboriginals and other indigenous peoples of the Americas,” European Journal of Human Genetics, vol. 19, no. 12, pp. 1276–1280, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. J. D. Rempel, K. B. Aborsangaya, M. P. Alphonse, and G. Y. Minuk, “The influence of North American Aboriginal ethnicity on pro-inflammatory and anti-inflammatory cytokine responses to IFN-alpha,” Journal of Viral Hepatitis, vol. 16, no. 4, pp. 292–297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Y. Minuk and J. Uhanova, “Viral hepatitis in the Canadian Iuit and First Nations populations,” Canadian Journal of Gastroenterology, vol. 17, no. 12, pp. 707–712, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. K. B. Aborsangaya, I. Dembinski, S. Khatkar, M. P. Alphonse, P. Nickerson, and J. D. Rempel, “Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: interaction with IL-10 gene polymorphisms,” Hepatology, vol. 45, no. 3, pp. 623–630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Angulo, J. M. Hui, G. Marchesini et al., “The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD,” Hepatology, vol. 45, no. 4, pp. 846–854, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. Indigenous and Northern Affairs Canada, First Nations in Manitoba, https://www.aadnc-aandc.gc.ca/eng/1100100020400/1100100020404.
  44. C. J. Ryan, M. Cooke, and S. T. Leatherdale, “Factors associated with heavy drinking among off-reserve First Nations and Métis youth and adults: evidence from the 2012 Canadian Aboriginal Peoples Survey,” Preventive Medicine, vol. 87, pp. 95–102, 2016. View at Publisher · View at Google Scholar
  45. G. Y. Minuk, S. Liu, K. Kaita et al., “Autoimmune hepatitis in a North American aboriginal/first nations population,” Canadian Journal of Gastroenterology, vol. 22, no. 10, pp. 829–834, 2008. View at Publisher · View at Google Scholar · View at Scopus